SG11201502089QA - Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer - Google Patents
Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancerInfo
- Publication number
- SG11201502089QA SG11201502089QA SG11201502089QA SG11201502089QA SG11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA
- Authority
- SG
- Singapore
- Prior art keywords
- liver cancer
- diagnosing liver
- kit
- subject
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261704425P | 2012-09-21 | 2012-09-21 | |
| PCT/SG2013/000414 WO2014046623A1 (en) | 2012-09-21 | 2013-09-23 | Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201502089QA true SG11201502089QA (en) | 2015-06-29 |
Family
ID=50341782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201502089QA SG11201502089QA (en) | 2012-09-21 | 2013-09-23 | Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150232943A1 (https=) |
| EP (1) | EP2898099A4 (https=) |
| JP (1) | JP2015530094A (https=) |
| KR (1) | KR20150058465A (https=) |
| CN (1) | CN104812914B (https=) |
| SG (1) | SG11201502089QA (https=) |
| WO (1) | WO2014046623A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101843173B1 (ko) * | 2014-10-24 | 2018-03-29 | 씨비에스바이오사이언스 주식회사 | 혈관 내피 세포 성장인자 수용체 억제제에 대한 감수성 예측 방법 |
| KR102116178B1 (ko) | 2017-05-10 | 2020-05-27 | 서울대학교산학협력단 | 간암 고위험군의 간암 발병 모니터링 또는 진단용 바이오마커 및 그 용도 |
| CN108048422A (zh) * | 2017-11-30 | 2018-05-18 | 天津市湖滨盘古基因科学发展有限公司 | 一种gtp酶，imap家族成员7突变蛋白及其应用 |
| CN110241198A (zh) * | 2019-05-30 | 2019-09-17 | 成都吉诺迈尔生物科技有限公司 | 一种表征hHRD同源重组缺陷的基因组重组指纹及其鉴定方法 |
| CN111610262A (zh) * | 2020-05-19 | 2020-09-01 | 上海鹿明生物科技有限公司 | 一种用于肝胆疾病诊断的代谢标志物 |
| WO2025111814A1 (zh) * | 2023-11-28 | 2025-06-05 | 何牮 | 一种b细胞的生物标志物组及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003081201A2 (en) * | 2002-03-21 | 2003-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same |
| EP1682904A2 (en) * | 2003-11-04 | 2006-07-26 | Roche Diagnostics GmbH | Method for distinguishing who classified aml subtypes |
| EP1830289A1 (en) * | 2005-11-30 | 2007-09-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods for hepatocellular carninoma classification and prognosis |
| WO2008138578A2 (en) * | 2007-05-11 | 2008-11-20 | Medical Prognosis Institute | Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
| EP2687609B1 (en) * | 2008-11-10 | 2017-01-04 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Method for treating solid tumor |
-
2013
- 2013-09-23 JP JP2015533022A patent/JP2015530094A/ja active Pending
- 2013-09-23 EP EP13838539.8A patent/EP2898099A4/en not_active Withdrawn
- 2013-09-23 WO PCT/SG2013/000414 patent/WO2014046623A1/en not_active Ceased
- 2013-09-23 CN CN201380060446.7A patent/CN104812914B/zh active Active
- 2013-09-23 KR KR1020157010267A patent/KR20150058465A/ko not_active Withdrawn
- 2013-09-23 US US14/429,317 patent/US20150232943A1/en not_active Abandoned
- 2013-09-23 SG SG11201502089QA patent/SG11201502089QA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014046623A1 (en) | 2014-03-27 |
| CN104812914B (zh) | 2020-07-24 |
| EP2898099A1 (en) | 2015-07-29 |
| EP2898099A4 (en) | 2016-05-25 |
| JP2015530094A (ja) | 2015-10-15 |
| US20150232943A1 (en) | 2015-08-20 |
| CN104812914A (zh) | 2015-07-29 |
| KR20150058465A (ko) | 2015-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201504663B (en) | Compositions and methods for diagnosing thyroid tumors | |
| SI3363901T1 (sl) | Sestavki in postopki za natančno identifikacijo mutacij | |
| SG11201503774PA (en) | Compositions and methods for increasing energy metabolism | |
| ZA201300795B (en) | Use of sigma ligands in opioid-induced hyperalgesia | |
| GB201110783D0 (en) | Methods and uses | |
| GB201216649D0 (en) | Agents and methods | |
| SG11201500922RA (en) | Methods and kits for screening patients with a cancer | |
| ZA201805056B (en) | Compositions and methods for identifying a risk of cancer in a subject | |
| GB201116774D0 (en) | Uses and methods | |
| IL232466A (en) | Preparations and Methods for Prostate Cancer Analysis | |
| SG11201502089QA (en) | Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer | |
| AP2014008113A0 (en) | Pipeline and methods | |
| IL235643A (en) | Kit and method for making a radioactive preparation | |
| PL2517687T3 (pl) | Sposób depilacji i zestaw do depilacji | |
| PL2559421T3 (pl) | Sposób i zestaw do depilacji | |
| EP2740801A4 (en) | SPHINGOMYLINE MEASURING METHOD AND MEASUREMENT KIT | |
| IL239426A0 (en) | Methods and compositions of biomarkers | |
| SG11201501838RA (en) | Completion assembly and methods for use thereof | |
| PL2517688T3 (pl) | Sposób depilacji i zestaw do depilacji | |
| IL231007A0 (en) | Means and methods for estimating toxicity related to blood cell formation | |
| EP2822455A4 (en) | MEDIUM AND METHOD FOR ASSESSING LIVER DISORDERS | |
| GB201201129D0 (en) | Kit and method | |
| GB201101021D0 (en) | Kit and method | |
| GB201120454D0 (en) | Kit and uses thereof | |
| GB201108085D0 (en) | Novel cancer therapies and methods |